FTC urged not to corner local drug makers

Fair Trade Commission (FTC)'s recent probe into 200 local drug companies for their illegal business practice, including rebate-offerings to area hospitals, could hit some damage to the pharmaceutical industry in an era of the Korea-U.S. FTA, said the Korea Pharmaceutical Manufacturers Association in a statement.

The statement also said that the FTC ought to establish a transparent medicine d...